Tresivac

tresivacrnmeasles, mumps and rubella vaccine (live) i.p. (freeze-dried) indicationrnfor active immunization against measles, mumps and rubella in infants & children, adolescents and young adults at risk. Route of administrationrnsubcutaneous injection immunization schedulernfirst dose of mmr is given at 9 months of agernsecond dose of mmr is given anytime between 15-18 months rnthird dose of mmr is given anytime between 4-6 years of age. Compositionrnthe reconstituted vaccine contains in each single human dose of 0.5 ml:rnnot less than 1000 ccid50 of measles virusrnnot less than 5000 ccid50 of mumps virusrnnot less than 1000 ccid50 of rubella virusrnpresentation:rnbox of 10 single dose vials. box of 10 ampoules of 0.5 ml diluent provided separately